Alain Schreiber, Director, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 74,300 shares at $14.08 ($1.0M) on 2007-09-19, disclosed to the SEC on 2007-09-19.
Open-market sale of $1.0M CADX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 17,100 | $231K | 22.4% |
| 2 | $13.97 | 100 | $1K | 0.1% |
| 3 | $14.00 | 36,235 | $507K | 49.1% |
| 4 | $14.01 | 600 | $8K | 0.8% |
| 5 | $14.02 | 200 | $3K | 0.3% |
| 6 | $14.03 | 100 |
| $1K |
| 0.1% |
| 7 | $14.04 | 100 | $1K | 0.1% |
| 8 | $14.05 | 16,811 | $236K | 22.9% |
| 9 | $14.06 | 1,202 | $17K | 1.6% |
| 10 | $14.07 | 752 | $11K | 1.0% |
| 11 | $14.08 | 100 | $1K | 0.1% |
| 12 | $14.09 | 1,000 | $14K | 1.4% |
| Total | $13.90 avg | 74,300 | $1.0M | 100% |
| Filing → |
| IMDZ | SELL | 2015-04-16 | $1.5M | — | Filing → |
| IMDZ | SELL | 2015-03-12 | $3.2M | — | Filing → |
| EGRX | BUY | 2014-02-20 | $5.0M | — | Filing → |